FDA has announced it has approved Torax Medical's LINX Reflux Management System for treatment of gastroesophageal reflux disease, according to a news release.
The LINX Reflux Management System is a single-use, surgically placed device for patients who continue to have chronic symptoms of GERD despite the use of maximum medical therapy for the treatment of reflux.
The LINX system is composed of a series of titanium beads, each with a magnetic core, connected together with independent titanium wires to form a ring shape. It is implanted at the lower esophageal sphincter, a circular band of muscle that closes the last few centimeters of the esophagus and prevents the backward flow of stomach contents.
Surgical treatment usually is reserved for people who have severe symptoms such as chronic GERD or a large hiatal hernia. Surgery is also an option for those who do not follow their recommended medical therapy or who want to avoid a lifetime of medical therapy.
Torax Medical is based in St. Paul, Minn.
Related Articles on FDA Clearances and Approvals:
Olympus Receives FDA Clearance for Thunderbeat Hand Instruments
JAMA Article Encourages FDA to Return Device Applications Lacking Trial Data on Women
Proposed Bill Would Tighten FDA Oversight of Medical Devices